Evidence map›Paper›PMID 35818743›Full record

ArticleClinical and experimental dental research2022

Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.

Shipra Gupta, Ritin Mohindra, Mohita Singla, Sagar Khera, Amit Kumar, Nilminie Rathnayake, Timo Sorsa, Andreas Pfützner, Ismo T Räisänen, Roop K Soni and 10 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and experimental dental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 3 countries.

Shipra GuptaUnit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.ORCID 0000-0003-2097-2459
Ritin MohindraDepartment of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Mohita SinglaUnit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sagar KheraDepartment of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Amit KumarUnit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Nilminie RathnayakeDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Timo SorsaDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Andreas PfütznerClinical Research Department, Diabetes Center and Practice, Pfützner Science and Health Institute, Mainz, Germany.
Ismo T RäisänenDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-5821-5299
Roop K SoniDepartment of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Poonam KantaDepartment of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Akanksha JainUnit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Krishan GaubaUnit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Kapil GoyalDepartment of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Mini P SinghDepartment of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Arnab GhoshDepartment of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Kamal KajalDepartment of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Varun MahajanDepartment of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Vikas SuriDepartment of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Ashish BhallaDepartment of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Post Graduate Institute of Medical Education and Research · INUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to validate an active matrix metalloproteinase (MMP-8) point-of-care diagnostic tool in COVID-19 patients with periodontal disease. SUBJECTS, MATERIALS, AND

methodsSeventy-two COVID-19-positive and 30 COVID-19-negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP-8 (aMMP-8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse-based kit for general disease activity. In COVID-19-positive patients, the kits were run again once the patients turned COVID-19 negative.

resultsThe overall (n = 102) sensitivity/specificity of the mouthrinse-based kits to detect periodontal disease was 79.41%/36.76% and that of site-specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746-0.869 (p < .001) and 0.740-0.872 (p < .001) (the aMMP-8 mouth rinse and site-specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP-8 mouth rinse test (p = .302) and aMMP-8 site-specific test (p = .189) once the subjects recovered from COVID-19.

conclusionsThe findings of the present study support the aMMP-8 point-of-care testing (PoCT) kits as screening tools for periodontitis in COVID-19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user-friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens.

Indexed as

COVID-19Periodontal DiseasesPeriodontitisCOVID-19 TestingHumansMatrix Metalloproteinase 8MouthwashesPoint-of-Care TestingMatrix Metalloproteinase 8Mouthwashesbiomarkersoral healthperiodontitisSARS CoV-2

Identifiers

PMID35818743
PMCPMC9350191
OpenAlexW4285077813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.